BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/1/2017 9:02:15 AM | Browse: 512 | Download: 514
Publication Name World Journal of Gastrointestinal Pharmacology and Therapeutics
Manuscript ID 35102
Country/Territory Iran
2017-06-19 01:26
Peer-Review Started
2017-06-21 10:35
To Make the First Decision
2017-07-25 00:49
Return for Revision
2017-07-26 01:19
2017-07-26 07:34
Second Decision
2017-08-25 07:45
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2017-09-06 00:43
Articles in Press
2017-09-06 00:43
Publication Fee Transferred
Edit the Manuscript by Language Editor
2017-09-19 01:41
Typeset the Manuscript
2017-10-31 03:56
Publish the Manuscript Online
2017-11-01 09:02
ISSN 2150-5349 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology and Hepatology
Manuscript Type Letter to the Editor
Article Title Fecal microbiota transplantation against irritable bowel syndrome? Rigorous randomized clinical trials are required
Manuscript Source Unsolicited Manuscript
All Author List Amin Talebi Bezmin Abadi
Author(s) ORCID Number
Amin Talebi Bezmin Abadi http://orcid.org/0000-0001-5209-6436
Funding Agency and Grant Number
Corresponding Author Amin Talebi Bezmin Abadi, PhD, Assistant Professor, Department of Bacteriology, Faculty of Medical Sciences, Tarbiat Modares University, P.O. Box 111, Tehran 14115, Iran. amin.talebi@modares.ac.ir
Key Words Fecal microbiota transplantation; Irritable bowel syndrome; Microbiota; Dysbiosis
Core Tip Apart from the interesting report by Halkjær et al, there is a long list of tasks concerning the application of fecal microbiota transplantation for the treatment of irritable bowel syndrome. Route of delivery and optimum dosage are the major concerns to consider before using in clinical practice.
Publish Date 2017-11-01 09:02
Citation Abadi ATB. Fecal microbiota transplantation against irritable bowel syndrome? Rigorous randomized clinical trials are required. World J Gastrointest Pharmacol Therap 2017; 8(4): 208-209
URL http://www.wjgnet.com/2150-5349/full/v8/i4/208.htm
DOI http://dx.doi.org/10.4292/wjgpt.v8.i4.208
Full Article (PDF) WJGPT-8-208.pdf
Full Article (Word) WJGPT-8-208.doc
Manuscript File 35102-Review.doc
Answering Reviewers 35102-Answering reviewers.pdf
Audio Core Tip 35102-Audio core tip.m4a
Conflict-of-Interest Disclosure Form 35102-Conflict-of-interest statement.pdf
Copyright License Agreement 35102-Copyright assignment.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s) 35102-Language certificate.pdf
Non-Native Speakers of English Editing Certificate 35102-Non-Native-Speakers-of-English-revision.docx
Peer-review Report 35102-Peer-review(s).pdf
Scientific Misconduct Check 35102-Scientific misconduct check.pdf
Scientific Editor Work List 35102-Scientific editor work list.pdf